865-299-6250 info@edpbiotech.com


This early detection blood test is aimed at driving the right people to confirmatory colonoscopy, reducing overall costs of screening programs and improving patient outcomes.

Early Detection Saves Lives

Early Detection Saves Lives

Easy to use tests that detect pre-cancer and cancer early are critical to patient survival.

EDP Biotech Corporation | Knoxville TN

Creating Simple Tests for Early Detection of Disease

Cancer is a global Disease

Cancer is a Big, Bad Global Disease

Colon Cancer is the 2nd leading cause of cancer deaths.

1.3 Million Diagnosed

700 Thousand Deaths*

Per Year


ColoMarker | Fight Cancer. Detect Early.


ColoPlex™ is an accurate early detection blood test which can drive the right people to confirmatory colonoscopy and aims to improve patient outcomes.

EDP Seeks Investors


EDP is committed to commercializing diagnostic products that address high unmet medical needs and deliver significant value to patients and shareholders.

EDP Seeks Distributors


EDP is committed to partnering with global distributors who are experts in their own geographies in commercializing in vitro diagnostic products.

EDP Biotech Corporation

We are committed to developing simple, accurate and cost-effective diagnostics that detect disease early.

EDP Biotech Corporation is a privately held medical device company focused on the development and commercialization of immunodiagnostic tests.

EDP performs research and develops products to identify and purify proteins present in the early stages of biological changes for production of in vitro diagnostic tests whose primary target is early detection.

EDP Biotech Corporation | Knoxville TN